Trial intelligence / Profile preview

Determinants of thiazide-induced hyponatremia in previously exposed elderly patients

NL-OMON31283Not yet recruiting

Sponsor
Amsterdam University Medical Center
Start
Aug 2007
Modality
Small Molecules
Countries
1
01

Overview

Open-label trial of hydrochlorothiazide in hypertension (HTN) (2 cohorts), sponsored by Amsterdam University Medical Center. Primary endpoint: Difference in ADH-AQP2 ratio. Planned start Aug 2007; status: not yet recruiting.

02

Drugs

hydrochlorothiazide
03

Conditions

hypertension (HTN)

Beyond the preview

Go deeper on NL-OMON31283.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON31283.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call